Roisin McGuigan

I have an extensive academic background in the life sciences, having studied forensic biology and human medical genetics in my time at Strathclyde and Glasgow Universities. My research, data presentation and bioinformatics skills plus my ‘wet lab’ experience have been a superb grounding for my role as a deputy editor at Texere Publishing. The job allows me to utilize my hard-learned academic skills and experience in my current position within an exciting and contemporary publishing company.

Content by Roisin McGuigan:

Research Field Drug discovery

Bearfaced Research

| Roisin McGuigan

A new method for discovering antibiotics makes use of an unusual source of complex microbial communities: bear saliva.

Research Field Drug discovery

Bringing Alzheimer’s in from the Cold

| Roisin McGuigan

With big pharma seemingly pulling out of the field, what hope remains for novel treatments for Alzheimer’s disease?

Research Field Biomedical engineering

Hot Off the Press

| Roisin McGuigan

What if, instead of waiting for a donor cornea to become available, you could just print one?

Research Field Cancer

Staying On Target

| Roisin McGuigan

What characteristics make a cancer therapy more likely to effectively treat disease?

Tools & Techniques Drug discovery

Medicina Ex Machina

| Roisin McGuigan

Artificial intelligence could have a huge impact on drug discovery.

Outside the Lab Drug discovery

A Problem Shared…

| Roisin McGuigan

It’s time for pharma to join the crowdsourcing revolution.

Research Field Analytical science

Mirror, Mirror…

| Roisin McGuigan

A tool to predict racemization could help prevent drug discovery dead ends

Tools & Techniques Clinical trials

Cherchez la Femme?

| Roisin McGuigan

A review of FDA data suggests that women are now better represented in clinical trials.

Disease Area Pain & critical care

Resisting Arrest

| Roisin McGuigan

Could resonance Raman spectroscopy be the key to your heart?

Disease Area Drug discovery

Pain and Vision Gain

| Roisin McGuigan

An analgesic is helping researchers explore new drug targets for sight-threatening diseases

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register